Mechanism, Consequences, and Therapeutic Targeting of Abnormal IL15 Signaling in Cutaneous T-cell Lymphoma.

Mechanism, Consequences, and Therapeutic Targeting of Abnormal IL15 Signaling in Cutaneous T-cell Lymphoma.

Item
http://www.wikidata.org/entity/Q38757938
Tethered IL-15 augments antitumor activity and promotes a stem-cell memory subset in tumor-specific T cellsMalignant inflammation in cutaneous T-cell lymphoma-a hostile takeoverEMT- and MET-related processes in nonepithelial tumors: importance for disease progression, prognosis, and therapeutic opportunities.Discovery and characterization of a novel humanized anti-IL-15 antibody and its relevance for the treatment of refractory celiac disease and eosinophilic esophagitis.Overview of the Use of Murine Models in Leukemia and Lymphoma Research.Covalent Modifications of Histone H3K9 Promote Binding of CHD3.Diminished microRNA-29b level is associated with BRD4-mediated activation of oncogenes in cutaneous T-cell lymphoma.Trial Watch: Immunostimulation with recombinant cytokines for cancer therapyA novel gene expression analytics-based approach to structure aided design of rexinoids for development as next-generation cancer therapeutics
P2860

Mechanism, Consequences, and Therapeutic Targeting of Abnormal IL15 Signaling in Cutaneous T-cell Lymphoma.

Item
http://www.wikidata.org/entity/Q38757938
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Mechanism, Consequences, and T ...... in Cutaneous T-cell Lymphoma.
@en
type
label
Mechanism, Consequences, and T ...... in Cutaneous T-cell Lymphoma.
@en
prefLabel
Mechanism, Consequences, and T ...... in Cutaneous T-cell Lymphoma.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P698
P932
P356
P1433
P1476
Mechanism, Consequences, and T ...... in Cutaneous T-cell Lymphoma.
@en
P2093
P2860
P304
P31
P356
10.1158/2159-8290.CD-15-1297
P433
P478
P50
P577
P698
P932